Cleared Traditional

K852542 - PALLADIUM SEED MODEL 100

K852542 is an FDA 510(k) clearance for PALLADIUM SEED MODEL 100, manufactured by Nuclear Medicine, Inc.. The device is a Class 2 Radiology device with product code IWI cleared through the Traditional 510(k) pathway after a 214-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1986
Decision
214d
Days
Class 2
Risk

K852542 is an FDA 510(k) clearance for the PALLADIUM SEED MODEL 100. Classified as Source, Isotope, Sealed, Gold, Titanium, Platinum (product code IWI), Class II - Special Controls.

Submitted by Nuclear Medicine, Inc. (Atlanta, US). The FDA issued a Cleared decision on January 14, 1986 after a review of 214 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5730 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Nuclear Medicine, Inc. devices

FDA 510(k) Submission Details - K852542

510(k) Number K852542 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 14, 1985
Decision Date January 14, 1986
Days to Decision 214 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
107d slower than avg
Panel avg: 107d · This submission: 214d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IWI Device Classification - Class 2, Special Controls

Product Code IWI Source, Isotope, Sealed, Gold, Titanium, Platinum
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5730
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.